NAYA Biosciences
Business Services · Florida, United States · <25 Employees
View Company Info for Free
About
Headquarters
5582 Broadcast Florida Ct, Sarasota, Florida, 3...Phone Number
(978) 878-9505Website
www.nayabiosciences.comRevenue
$6.2 MillionStock Symbol
NAYAIndustry
Most Recent Scoops
Who is NAYA Biosciences
NAYA Biosciences Org Chart
Is NAYA Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if NAYA Biosciences had a recent Job posting/layoffs
Funding: Get notified immidiatlly once NAYA Biosciences has new funding data
Earning: See what the market has to say on NAYA Biosciences recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at NAYA Biosciences
Product Launch: Get notified when NAYA Biosciences launches new products
Check if NAYA Biosciences has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if NAYA Biosciences is spiking on competitors!
NAYA Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to NAYA Biosciences
Compare insights from companies similar to NAYA Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
NAYA Biosciences Employee Growth Rate
Percentage of growth
1st year Mask
2nd year Mask
NAYA Biosciences Tech Stack
A closer look at the technologies used by NAYA Biosciences
Most Recent Scoops
NAYA Biosciences News & Media
NAYA Biosciences Announces Development of NY-500, a Novel AI-Optimized PD-1 x VEGF Bifunctional Antibody
• PD-1 x VEGF antibodies show potential to surpass checkpoint inhibitors as standard-of-care in multiple oncology indicationsNAYA Biosciences to Present Translational Insights to Support Phase I/IIa Clinical Trials for its GPC3-Targeting NK Engager Bispecific Antibody at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Abstracts demonstrate reversal of resistance to PD1 checkpoint blockade and predictive AI model of HCC survival rate Abstracts demonstrate reversal of resistance to PD1 checkpoint blockade and predictive AI model of HCC survival rateNAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma
SARASOTA, Fla. and MIAMI, Oct. 24, 2024 (GLOBE NEWSWIRE) -- NAYA Biosciences (“NAYA”) (NASDAQ: NAYA), a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and fertility, today announced an update regarding its clinic trial plans. The Company received regulatory approval from the Israeli Ministry of Health in July 2024 and subsequent institutional review board clearance to initiate patient enrollment in up to 7 academic centeINVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)
Combined company to expand portfolio of clinical & commercial-stage assets in fertility, oncology, and autoimmune diseases Combined company to expand portfolio of clinical & commercial-stage assets in fertility, oncology, and autoimmune diseases
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Frequently Asked Questions Regarding NAYA Biosciences
NAYA Biosciences is building a group of companies leveraging the next generation of biotechnologies to increase patient access to life-transforming treatments in oncology, fertility, and regenerative medicine.... Read More